- C-terminal truncating alterations in CDH1 escape the nonsense-mediated mRNA pathway. It’s possible that these truncated proteins retain partial function, and variants in this region must be interpreted with caution.
- Using clinical data, molecular evidence, and structural information, we characterized truncating alterations in the CDH1 gene that were identified downstream of the NMD boundary in a large diagnostic laboratory cohort of ~400,000 alleles.
- We reported three pathogenic C-terminal truncations in families meeting International Gastric Cancer Linkage Consortium (IGCLC) diagnostic criteria. Additionally, we identified the most C-terminal pathogenic mutation in our cohort, which occurred de novo in an individual with lobular breast cancer. Identifying the most C-terminal mutation allows us to classify other, upstream C-terminal truncating alterations as pathogenic or likely pathogenic.
![overlay-bottom[1]](https://ambrygen.com/wp-content/uploads/2026/02/overlay-bottom1.svg)